Delivery Order SPE2DB25D3109-SPE2DB25FPLCC
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Boostrix TDAP vaccine in 0.5ML syringes. This competitively awarded, non-set-aside contract carries a ceiling value of $1,865.25 with a firm fixed price structure and an ultimate completion date of September 2, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a transactional...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in 0.5ml syringe format, valued at $3,918.45 under a firm fixed-price contract type. The award was made on August 22, 2025, with an ultimate completion date of August 25, 2025. This delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in syringe form (0.5mL) valued at $1,863.95 under a firm fixed price contract. The award was made on August 20, 2025, with an ultimate completion date of August 21, 2025, and represents a non-set-aside competitive award. Performance of this delivery order will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Boostrix TDAP vaccine in 0.5mL syringes, with a ceiling value of $3,582.05. The contract is a firm fixed-price delivery order with an ultimate completion date of July 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was utilized in this competitive award. This delivery order operates...
- The Defense Logistics Agency awarded a $4,733.48 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Boostrix TDAP vaccine in 0.5mL syringes. This non-set-aside contract, which carries an ultimate completion date of August 14, 2025, operates under a firm fixed price structure. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this order. The contract represents a small-value transaction typical of routine...
- The Defense Logistics Agency awarded a $13,446.66 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Boostrix TDAP vaccine in 0.5mL syringes. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this competitive award. This delivery order is issued under...
- The Defense Logistics Agency awarded a $16,986.52 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Boostrix TDAP vaccine in 0.5mL syringes. This is a firm fixed-price delivery order with an ultimate completion date of August 27, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The contract includes no set-aside designation and was competitively awarded through open procurement channels. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Boostrix TDAP vaccine in 0.5 mL syringes. This competitively awarded, non-set-aside contract carries a ceiling value of $4,470.50 and is structured as a firm fixed price delivery order with an ultimate completion date of August 1, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains operations as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Boostrix TDAP vaccine in syringe form (0.5 mL). This firm fixed-price delivery order, valued at $1,044.92, represents a non-competitive set-aside award and is scheduled for completion by September 10, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $133,843.21 on August 12, 2025, for the supply of Boostrix TDAP vaccine in 0.5mL syringes. The contract utilizes a firm fixed-price structure with no set-aside designation, indicating competitive award. Performance will be conducted at the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 13, 2025. This delivery order is executed under...
- SPE2DB25D3109Indefinite Delivery Contract
- SPE2DB25D3109-SPE2DB25FPLCCDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Boostrix TDAP vaccine in 0.5 mL syringes. This firm fixed-price contract, valued at $1,064.40, represents a non-competitive set-aside delivery against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a total value of $999,999,999.00 through December 2026. The delivery order was completed by September 8, 2025, with performance conducted at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is part of AmerisourceBergen's comprehensive pharmaceutical supply agreement serving the Defense Health Agency and broader military healthcare systems. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a wide range of pharmaceutical products, vaccines, medical devices, and healthcare commodities to support military personnel and veteran care worldwide. The Boostrix TDAP vaccine delivery fulfills routine immunization requirements across the federal health system, consistent with the contractor's extensive portfolio of medical supply deliveries managed through DLA's supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/5/25 |